Markus Gastpar

TL;DR: There was a significant naloxone-associated reduction in overall physician-rated symptoms in schizophrenic patients concurrently treated with neuroleptic medication but not in medication-free schizophrenics, while self-ratings of auditory hallucinations showed improvement only in Neuroleptic-treated schizophrenics.

TL;DR: The statement on prophylactic use of anticholinergics in patients on neuroleptic treatment is the second of the proposed series of consensus statements on key issues in biological research and treatment of psychiatric problems.

TL;DR: No significant differences between distinct subgroups of psychiatric patients with respect to B max or Kd values for platelet 3H-imipramine binding could be established and no significant difference between psychiatric patients and controls was obtained.

TL;DR: Early onset of clinical effect and minimal side effects indicate that citalopram is possible a new effective antidepressant.

TL;DR: Rheumatoid factor, antimitochondrial and anti-basemembrane antibodies, and two other auto-antibodies could not be found in a higher frequency than in normals, whereas the occurrence of the thyroglobulin auto- Antibodies was just above the upper limit of normals.